Mycophenolate mofetil attenuates walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine

Transplantation Proceedings

Volumn 36, Issue 4, 2004, Pages 1004-1006

  Silva, S L ^a,b,d   Silva, S F R ^a,b   Cavalcante, R O ^a   Mota, R S ^a   Carvalho, R A ^c   Moraes, M O ^a   Campos, H H ^a   Moraes, M E A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF FORTALEZA   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; INOCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME; WALKER CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CELL DIVISION; CYCLOSPORINE; MALE; MYCOPHENOLIC ACID; RATS; RATS, WISTAR;

EID: 2942679111     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.03.057     Document Type: Conference Paper

References (12)

1. Penn I. Transplant Proc. 11:1979;1047-1051
2. London N.J., Farmery S.M., Will E.J. Lancet. 346:1995;403
3. Cohn R.G., Mirkovich A., Dunlap B. Transplantation. 68:1999;411
4. Sweeney M.J., Gerzon K., Harris P.N., et al. Cancer Res. 32:1972;1795
5. Carter S.B., Franklin T.J., Jones D.F., et al. Nature. 223:1969;848
6. Suzuki S., Kimura T., Ando K., et al. J Antibiot. 22:1969;297
7. Tressler R.J., Garvin L.J., Slate D.L. Int J Cancer. 57:1994;568
8. Weber G. N Engl J Med. 296:1997;541
9. Weber G. Clin Biochem. 16:1983;57
10. Lowe J.K., Brox L., Henderson J.F. Cancer Res. 37:1977;736-743
11. Weber G., Nagai M., Natsumeda Y., et al. Adv Enzyme Regul. 31:1991;45-67
12. Natsumeda Y., Pradja N., Donohue J.P., et al. Cancer Res. 44:1984;2475